
Publications: list
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. (2007). Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet;369(9580):2161-70.
- Kitchener H, Nelson L, Adams J, et al (2007). Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer; 121(11):2484-91
- Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. (2008). Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ;336(7652):1056-8.
- Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC. (2008). Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 98(10):1704-9.
- Vallely LA, Roberts SA, Kitchener HC, Brabin L. (2008). Informing adolescents about human papillomavirus vaccination: What will parents allow? Vaccine 26 (18): 2203-10.
- Kitchener H, Walker P, Nelson L, Hadwin R, Patnick J, Anthony G, Sargent A, Wood J, Moore C, Cruickshank M. (2008). HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. BJOG. 115:1001–1007.
- Winters U, Kitchener H, Stern P et al (2008). Phase II trial of Imiquimod followed by TA-CIN HPV16/18 vaccine in the management of vulval intraepithelial neoplasia. Clinical Cancer Research (In Press).
This website will look much better in a web browser that supports web standards, but it is accessible to any browser or Internet device.